Health ❯ Healthcare ❯ Medical Treatments

Cell Therapy

Duchenne Muscular Dystrophy CAR T-cell Therapy Zemcelpro UM171 Cell Therapy Regulatory T Cells Stem Cell Therapy Autoimmune Disorders Autologous Cell Therapy iPS Cells CAR-T Cell Therapy

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

A 9–3 advisory vote and critical FDA reviews increase doubt about final approval ahead of the August 22 PDUFA date.

FDA Staff Flags Major Flaws in Capricor’s Deramiocel Data

Single CAR-T Infusion Puts Three Severe Autoimmune Diseases in Remission

FDA Grants Orphan Drug Status to Cellenkos’ CK0804 for Myelofibrosis

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

EU Grants Conditional Approval to Zemcelpro for Adults Needing Transplants Without a Matched Donor

CAR T-Cell Therapy Yields Lasting Remission in Chronic Inflammatory Demyelinating Polyneuropathy